Smart mRNA

LEHI, Utah, August 6, 2026 CancerVax announced a significant preclinical milestone with new in vitro findings demonstrating that its...

LEHI, Utah, July 14, 2026 CancerVax announced the successful development and in vitro validation of a novel Polyepitope Smart...

LEHI, Utah — December 23, 2025 — CancerVax, a pre-clinical biopharmaceutical innovator, has released a year-end scientific and strategic...